BACKGROUND People who are physically active have at least a 30% lower risk of death during follow-up compared
In 1969, the first running race in Europe (the Eremitage Race) took place in Denmark; 2,344 men and women finished the distance of 7.6 miles. Unfortunately, a 46-year-old naval officer died of a myocardial infarction during this event. As a result of this death, the event organizers hesitated to continue running races, reasoning that perhaps they were too strenuous and possibly dangerous for the general population. (The race has continued and has gained in popularity.) Subsequently, during the 1970s, when jogging gained momentum, several reports of deaths during jogging were published (7) (8) (9) (10) (11) (12) (13) .
The Copenhagen City Heart Study (14, 15) reported that the relative intensity of walking and cycling and not the duration was of most importance in relation to all-cause and CHD mortality. Subsequently, the Copenhagen City Heart Study showed that the increase in survival among joggers was 6.2 years in men and 5.6 years in women. This particular analysis was performed in a random sample of 1,878 joggers who were followed for up to 35 years and compared with 16,827 nonjoggers. Jogging up to 2.5 h per week at a slow or average pace and a frequency of #3 times per week was associated with the lowest mortality. Those who jogged >4 h per week, at a fast pace, and >3 times per week appeared to lose many of the longevity benefits noted with less strenuous doses of jogging (16) . This finding was somewhat surprising.
In the present study, we explore in more detail whether a U-shaped association exists between mortality and dose of jogging as calibrated by pace, quantity, and frequency of jogging. All subjects from the original sample were invited to all subsequent examinations, and a new random sample of younger men and women was included.
METHODS
Details have been described elsewhere (1, 17) .
In the present analyses, we excluded participants with a history of CHD (n ¼ 513), stroke (n ¼ 262), and cancer (n ¼ 469), leaving 5,048 men and women (1,098 healthy joggers and 3,950 healthy nonjoggers) for analyses.
SURVEY METHODS. Established procedures and examinations for cardiovascular (CV) epidemiological surveys were used (18) . Physical activity in leisure time was graded as 1 of 4 levels in all 4 surveys using The Copenhagen City Heart Study Leisure Time Physical Activity Questionnaire (1). Levels of activity were defined as follows: group I, almost entirely sedentary (e.g., reading, watching television or movies, engaging in light physical activity, such as walking or biking for <2 h per week); group II, light physical activity for 2 to 4 h per week; group III, light physical activity for more than 4 h per week or more vigorous activity for 2 to 4 h per week (e.g., brisk walking, fast biking, heavy gardening, sports that cause perspiration or exhaustion); and group IV, high vigorous physical activity for more than 4 h per week or regular heavy exercise or competitive sports several times per week. The activity questionnaire has been shown to discriminate between sedentary people and their more active counterparts with respect to maximal oxygen uptake (19) .
In the 2001 to 2003 survey, we included questions on the weekly quantity of jogging, frequency of jogging, and the subject's own perception of pace (slow, average, fast). We found that a relative scale of pace (intensity) is more appropriate than an absolute scale when the age span is very wide (20 Values are mean AE SD or n (%).
Schnohr et al. Quantity, frequency, and pace of jogging in relation to all-cause mortality. HR ¼ hazard ratio. *p < 0.10; **p < 0.05; ***p < 0.01; ****p < 0.001.
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DISCUSSION
In this prospective, observational study, which included 1,098 healthy joggers between 20 and 86 years of age who were followed up for 12 years, we compared the long-term all-cause mortality rates of light, moderate, and strenuous joggers with the long-term mortality rate of sedentary nonjoggers. We found a U-shaped association between jogging and mortality. The lowest mortality was among light joggers in relation to pace, quantity, and frequency of jogging. Moderate joggers had a significantly higher mortality rate compared with light joggers, but it was still lower than that of sedentary nonjoggers, whereas strenuous joggers had a mortality rate that was not statistically different from that of sedentary nonjoggers (Central Illustration).
It should be emphasized that even slow jogging A recently published study of 55,000 adults between 18 and 100 years of age who were followed up for a mean of 15 years, using comprehensive analyses that controlled for potential confounding factors, reported that runners as compared with nonrunners had 30% and 45% lower risks of allcause and CV mortality, respectively, with a mean improvement in life expectancy of 3 years (21). Forest plot indicating all-cause mortality in light, moderate, and strenuous joggers compared with sedentary nonjoggers.
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Again, however, maximal CV longevity benefits were noted with moderate doses of running (specifically 6 to 12 miles per week), running durations of approximately 50 to 120 min per week, a running frequency of approximately 3 times per week, and a modest pace of approximately 6 to 7 miles per hour.
Our findings are aligned in that a U-shaped or reverse J-shaped relationship was noted, whereas higher doses of running were associated with loss of approximately one-third to one-half of the CV mortality benefits linked to moderate doses of running.
In fact, the most favorable running regimen for reducing CV mortality in that study was 6 miles per week, 3 running days per week, and a pace of 7 miles per hour.
Other studies that did not focus solely on joggers 
